\documentclass[twocolumn,twoside]{article}
\makeatletter\if@twocolumn\PassOptionsToPackage{switch}{lineno}\else\fi\makeatother

\usepackage{amsfonts,amssymb,amsbsy,latexsym,amsmath,tabulary,graphicx,times,xcolor}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Following additional macros are required to function some 
% functions which are not available in the class used.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\usepackage{url,multirow,morefloats,floatflt,cancel,tfrupee}
\makeatletter


\AtBeginDocument{\@ifpackageloaded{textcomp}{}{\usepackage{textcomp}}}
\makeatother
\usepackage{colortbl}
\usepackage{xcolor}
\usepackage{pifont}
\usepackage[nointegrals]{wasysym}
\urlstyle{rm}
\makeatletter

%%%For Table column width calculation.
\def\mcWidth#1{\csname TY@F#1\endcsname+\tabcolsep}

%%Hacking center and right align for table
\def\cAlignHack{\rightskip\@flushglue\leftskip\@flushglue\parindent\z@\parfillskip\z@skip}
\def\rAlignHack{\rightskip\z@skip\leftskip\@flushglue \parindent\z@\parfillskip\z@skip}

%Etal definition in references
\@ifundefined{etal}{\def\etal{\textit{et~al}}}{}


%\if@twocolumn\usepackage{dblfloatfix}\fi
\usepackage{ifxetex}
\ifxetex\else\if@twocolumn\@ifpackageloaded{stfloats}{}{\usepackage{dblfloatfix}}\fi\fi

\AtBeginDocument{
\expandafter\ifx\csname eqalign\endcsname\relax
\def\eqalign#1{\null\vcenter{\def\\{\cr}\openup\jot\m@th
  \ialign{\strut$\displaystyle{##}$\hfil&$\displaystyle{{}##}$\hfil
      \crcr#1\crcr}}\,}
\fi
}

%For fixing hardfail when unicode letters appear inside table with endfloat
\AtBeginDocument{%
  \@ifpackageloaded{endfloat}%
   {\renewcommand\efloat@iwrite[1]{\immediate\expandafter\protected@write\csname efloat@post#1\endcsname{}}}{\newif\ifefloat@tables}%
}%

\def\BreakURLText#1{\@tfor\brk@tempa:=#1\do{\brk@tempa\hskip0pt}}
\let\lt=<
\let\gt=>
\def\processVert{\ifmmode|\else\textbar\fi}
\let\processvert\processVert

\@ifundefined{subparagraph}{
\def\subparagraph{\@startsection{paragraph}{5}{2\parindent}{0ex plus 0.1ex minus 0.1ex}%
{0ex}{\normalfont\small\itshape}}%
}{}

% These are now gobbled, so won't appear in the PDF.
\newcommand\role[1]{\unskip}
\newcommand\aucollab[1]{\unskip}
  
\@ifundefined{tsGraphicsScaleX}{\gdef\tsGraphicsScaleX{1}}{}
\@ifundefined{tsGraphicsScaleY}{\gdef\tsGraphicsScaleY{.9}}{}
% To automatically resize figures to fit inside the text area
\def\checkGraphicsWidth{\ifdim\Gin@nat@width>\linewidth
	\tsGraphicsScaleX\linewidth\else\Gin@nat@width\fi}

\def\checkGraphicsHeight{\ifdim\Gin@nat@height>.9\textheight
	\tsGraphicsScaleY\textheight\else\Gin@nat@height\fi}

\def\fixFloatSize#1{}%\@ifundefined{processdelayedfloats}{\setbox0=\hbox{\includegraphics{#1}}\ifnum\wd0<\columnwidth\relax\renewenvironment{figure*}{\begin{figure}}{\end{figure}}\fi}{}}
\let\ts@includegraphics\includegraphics

\def\inlinegraphic[#1]#2{{\edef\@tempa{#1}\edef\baseline@shift{\ifx\@tempa\@empty0\else#1\fi}\edef\tempZ{\the\numexpr(\numexpr(\baseline@shift*\f@size/100))}\protect\raisebox{\tempZ pt}{\ts@includegraphics{#2}}}}

%\renewcommand{\includegraphics}[1]{\ts@includegraphics[width=\checkGraphicsWidth]{#1}}
\AtBeginDocument{\def\includegraphics{\@ifnextchar[{\ts@includegraphics}{\ts@includegraphics[width=\checkGraphicsWidth,height=\checkGraphicsHeight,keepaspectratio]}}}

\DeclareMathAlphabet{\mathpzc}{OT1}{pzc}{m}{it}

\def\URL#1#2{\@ifundefined{href}{#2}{\href{#1}{#2}}}

%%For url break
\def\UrlOrds{\do\*\do\-\do\~\do\'\do\"\do\-}%
\g@addto@macro{\UrlBreaks}{\UrlOrds}



\edef\fntEncoding{\f@encoding}
\def\EUoneEnc{EU1}
\makeatother
\def\floatpagefraction{0.8} 
\def\dblfloatpagefraction{0.8}
\def\style#1#2{#2}
\def\xxxguillemotleft{\fontencoding{T1}\selectfont\guillemotleft}
\def\xxxguillemotright{\fontencoding{T1}\selectfont\guillemotright}

\newif\ifmultipleabstract\multipleabstractfalse%
\newenvironment{typesetAbstractGroup}{}{}%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\usepackage[authoryear]{natbib}



\newif\ifnokeywords\nokeywordsfalse

\makeatletter\input{size10-pointfive.clo}\makeatother%
\definecolor{kwdboxcolor}{RGB}{242,242,242}
\usepackage[hidelinks,colorlinks=true,allcolors=blue]{hyperref}
\linespread{1}                 
\def\floatpagefraction{0.8}

\usepackage[paperheight=11.69in,paperwidth=8.26in,top=1in,bottom=1in,left=1in,right=.75in,headsep=24pt]{geometry}

\usepackage{multirow-custom}

\makeatletter

\def\hlinewd#1{%
  \noalign{\ifnum0=`}\fi\hrule \@height #1%
  \futurelet\reserved@a\@xhline}
\def\tbltoprule{\hlinewd{1pt}\\[-14pt]}
\def\tblbottomrule{\noalign{\vspace*{6pt}}\hline\noalign{\vspace*{2pt}}}
\def\tblmidrule{\hline\noalign{\vspace*{2pt}}}



\let\@articleType\@empty
\let\@journalDoi\@empty
\let\@journalVolume\@empty
\let\@journalIssue\@empty
\let\@crossMarkLink\@empty
\let\@receivedDate\@empty
\let\@acceptedDate\@empty
\let\@revisedDate\@empty
\let\@publishedDate\@empty
\let\@copyrightYear\@empty
\let\@firstPage\@empty
\def\articleType#1{\gdef\@articleType{#1}}
\def\journalDoi#1{\gdef\@journalDoi{#1}}
\def\crossMarkLink#1{\gdef\@crossMarkLink{#1}}
\def\receivedDate#1{\gdef\@receivedDate{#1}}
\def\acceptedDate#1{\gdef\@acceptedDate{#1}}
\def\revisedDate#1{\gdef\@revisedDate{#1}}
\def\publishedDate#1{\gdef\@publishedDate{#1}}
\def\copyrightYear#1{\gdef\@copyrightYear{#1}}
\def\journalVolume#1{\gdef\@journalVolume{#1}}
\def\journalIssue#1{\gdef\@journalIssue{#1}}
\def\firstPage#1{\gdef\@firstPage{#1}}
\let\@issuelogo\@empty%
\let\@issuelogoex\@empty%
\def\issuelogo#1{\gdef\@issuelogo{#1}}
\def\issuelogoex#1{\gdef\@issuelogoex{#1}}


\def\author#1{%
  \gdef\@author{%
    \hskip-\dimexpr(\tabcolsep)\hskip5pt%
    \parbox{\dimexpr\textwidth-1pt}%
    {\fontsize{11}{13}\selectfont\raggedright #1}%
  }%
}


\usepackage{pharmascope-abs}
\usepackage{caption}
\usepackage{lastpage}
\usepackage{fancyhdr}
\usepackage[noindentafter,explicit]{titlesec}
\usepackage{fontspec}

\setmainfont[%
BoldFont=cambriab.ttf,%
ItalicFont=CAMBRIAI.TTF,%
BoldItalicFont=CAMBRIAZ.TTF]{Cambria.ttf}
\lefthyphenmin = 3

\def\title#1{%
  \gdef\@title{%
      \vspace*{-40pt}%
       \ifx\@articleType\@empty\else{\fontsize{10}{12}\scshape\selectfont\hspace{8pt}\@articleType\hfill\mbox{}\par\vspace{2pt}}\fi%
       \minipage{\linewidth}
         \hrulefill\\[-0.7pt]%%{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}\hfill
         \mbox{~}\hspace{5pt}\parbox{.1\linewidth}{\IfFileExists{images/\@issuelogo.\@issuelogoex}{\includegraphics[width=79pt,height=61pt]{images/\@issuelogo.\@issuelogoex}}{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}}\hfill
         \fcolorbox{kwdboxcolor}{kwdboxcolor}{\parbox{.792\linewidth}{%
          \begin{center}\fontsize{17}{17}\selectfont\scshape\vskip-7pt International Journal of Research in Pharmaceutical Sciences\hfill\end{center}%
          \vspace*{-10pt}\hspace*{4pt}{\fontsize{8}{9}\selectfont Published by JK Welfare \& Pharmascope Foundation\hfill  Journal Home Page: \href{www.ijrps.com}{\color{blue}\underline{\smash{www.ijrps.com}}}}\hspace*{4pt}\mbox{}}}%
       \par\vspace*{-1pt}\rule{\linewidth}{1.3pt}%
       \endminipage%
    \par\vspace*{9.2pt}\parbox{.98\linewidth}{\linespread{.9}\raggedright\fontsize{14}{17}\selectfont #1}%
    \vspace*{-8pt}%
  }
}


\setlength{\parindent}{0pt}
\setlength{\parskip}{0.4pc plus 1pt minus 1pt}

\def\abbrvJournalTitle{Int. J. Res. Pharm. Sci.}

\fancypagestyle{headings}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
}\pagestyle{headings}

                                                         
\fancypagestyle{plain}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}%
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
  \ifx\@firstPage\@empty\else\setcounter{page}{\@firstPage}\fi
}


\def\NormalBaseline{\def\baselinestretch{1.1}}
\usepackage{textcase}
\setcounter{secnumdepth}{0}

\titleformat{\section}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{13}\selectfont}
{\thesection}
{6pt}
{\MakeTextUppercase{#1}}
[]
\titleformat{\subsection}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsection}
{6pt}
{#1}
[]
\titleformat{\subsubsection}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsubsection}
{6pt}
{#1}
[]
\titleformat{\paragraph}[block]{\NormalBaseline\filright\fontsize{10.5}{10}\selectfont}
{\theparagraph}
{6pt}
{#1}
[]
\titleformat{\subparagraph}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubparagraph}
{6pt}
{#1}
[]

\titlespacing{\section}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsubsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\paragraph}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subparagraph}{0pt}{.5\baselineskip}{.5\baselineskip}

\captionsetup[figure]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}
\captionsetup[table]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}

\def\bibyear#1{#1}
%\def\bibjtitle#1{#1}   %%Publisher request
\def\bibauand{}
\setlength\bibsep{3pt}
\setlength\bibhang{8pt}

\makeatother
\date{}


\usepackage{float}

\newcommand{\texttildeapprox}{{\fontfamily{pcr}\selectfont\texttildelow}}

\begin{document}


\def\RunningAuthor{Arun Radhakrishnan and Ajmal K T}
\firstPage{4135}
\articleType{Review Article}
\receivedDate{01 Mar 2020}
\acceptedDate{03 Apr 2020}
\revisedDate{31 Mar 2020}
\journalVolume{2020, 11}
\journalIssue{3}
\journalDoi{ijrps.v11i3.2618}
\copyrightYear{2020}
\def\authorCount{2}
\def\affCount{1}

\def\journalTitle{International Journal of Research in Pharmaceutical Sciences}

\title{Enhancing the content uniformity of low dose drugs by using different granulation techniques}
\author{Ajmal~K~T, 
            Arun~Radhakrishnan\textsuperscript{*}~\\[5pt]{Department of Pharmaceutics JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamilnadu, India}}

\begin{abstract}
Progress in pharmaceutical research has delivered very strong medications, which require cautious definition and creation so as to deliver strong oral measurement structures with satisfactory homogeneity and physical stability. Mixing and formulation of low dose medications can be individually testing because of issues identified with isolation, content uniformity and physical stability. A cautious control on these variables is vital while fabricating low dose drugs. Choice of excipients for the particular strides during detailing/process improvement is basic to build up a homogenous and isolation free low portion definition. Numerous sorts of categories of gear have been intended towards encourage blending of low portion drugs with excipients. A side from traditional detailing strategies (like wet granulation, dry granulation, and direct compression) different new procedures have been announced, for example, high shear granulation, requested blending and spry drying. These innovative headways ensure enhanced the assembling and nature of low dose drugs items by accomplishing their predefined goal of substance consistency through outblending and plan of low dose drugs. Blending and detailing of low portion drugs are advanced work and includes part of issues related to isolation, content consistency and physical soundness which can be constrained by right choice of material, strategy and machine\textit{.} This article surveys current headways identified with plan systems of low dose drugs.
\end{abstract}\def\keywordstitle{Keywords}

\begin{keywords}Content uniformity,\newline Physical stability,\newline Granulation techniques
\end{keywords}
\twocolumn[ \maketitle {\printKwdAbsBox}]
\makeatletter{\raggedright\textsuperscript{*}Corresponding Author\par Name:\ Arun~Radhakrishnan~\\ Phone:\ 7402222019~\\  Email:\ arun.r@jssuni.edu.in
        \par}\vspace*{-11pt}\hrulefill\par{\fontsize{12}{14}\selectfont ISSN: 0975-7538}\par% 
        \textsc{DOI:}\ \href{https://doi.org/10.26452/\@journalDoi}{\textcolor{blue}{\underline{\smash{https://doi.org/10.26452/\@journalDoi}}}}\par%
        \vspace*{-11pt}\hrulefill\\{\fontsize{9.12}{10.12}\selectfont Production and Hosted by}\par{IJRPS |~\href{www.ijrps.com}{www.ijrps.com}}\par%
        \vspace*{-2pt}{\fontsize{9.12}{10.12}\selectfont\textcopyright\ \@copyrightYear\ $|$ All rights reserved.}\par%
        \vspace*{-11pt}\rule{\linewidth}{1.2pt}
        \makeatother
        
    
\section{Introduction}
Progress in pharmaceutical research has delivered very strong medications, which require cautious definition and creation so as to deliver strong oral measurement structures with satisfactory homogeneity and physical stability. Guaranteeing the physical soundness of a powder mix used for generation of tablets or cases speaks to a significant quality affirmation thought. The substance consistency quality control strategy used for the maximum number tablets and cases which are the subject of legitimate monograph is given by the investigation of average value of medication substance of 20 tablets that were placed together. Table~\ref{tw-45ccd3d74c72} introduces low dose drugs that requires content uniformity test in Indian Pharmacopeia 1996 release. Many regulatory administrative specialists are practicing authority on observing content uniformity by indicating one tablet examines aimed at the substance under dynamic fixing. The obtained viability for a substance consistency standard must rely upon the accuracy of tablet measure information, the normal quantity of the tablets inspected and any factual strategies engaged with the structure of the particular. The determinations in both United States Pharmacopeia (1975) and the British Pharmacopeia (1973 and 1975, 1977 Additions) rely on flawed tablets that are distinguished in a statistically little example. The viability of the above techniques for monitoring substance consistency had been described about, and certain constraints called attention to. A few creators have introduced randomized blending hypothesis to anticipate the size of the molecule prerequisites for the medication powder vital if the portion uniform content consistency of the tablets are to constrast with certain foreordained details. \unskip~\cite{739174:17555197} presented the innovation requested blending which thinks about the adherence of fine medication particles to the outside of bigger excipient particles. Understood in the use of blending hypothesis is the supposition that the measure of medication is typically dispersed inside the tablet bunch. While it might be alluring that the appropriation is typical or if nothing else balanced about the mean there is little motivation to accept this is accomplished in practice \unskip~\citep{739174:17555195}. The B.P. perceived the significance of the issue in 1973 and presented a necessity of individual tablet examine for smaller scale portion arrangements (tablets containing under 2 mg or 2\% w/w of dynamic medication) \unskip~\citep{739174:17555201}. Fixed portion blend (FDC) tranquilize items are basic for practically all helpful regions. A wide range of kinds of oral, parenteral, and inward breath FDC details are economically available. Reviews of the Physician' Desk Reference (PDR) and United States Pharmacopeia(USP) in 2005 uncovered that there were 150 FDC items, primarily cardiovascular and hack prescriptions, recorded in PDR and 80 in USP \unskip~\citep{739174:17555214}. Most recent pharmacopoeial rules guarantee the uniformity of measurements units by consistency of dose unit tests. The term content consistency of dose unit is characterized as the level of consistency in the measure of the dynamic substance among dose units. The consistency of measurement units can be shown by either content consistency or mass variety. The substance consistency technique might be applied in all cases. Anyway the test for mass variety is relevant for chosen measurement shapes as given in \unskip~\citep{739174:17555216}. The proposal given result quality research establishment (PQRI) with respect to mix consistency was checked on lastly acknowledged by US FDA. As indicated by this suggestion, inspecting plans for process approval clumps incorporate distinguishing proof of at any rate 10 areas in the blender to pull mix tests and ID of in any event 20 areas all through the pressure or filling activity to acquire dose units. Mix test criteria incorporates relative standard deviation (RSD) \ensuremath{\leq } 5.0\% and all people ought to be inside the mean \ensuremath{\pm} 10\% (outright). Measurements unit criteria incorporates RSD of all people \ensuremath{\leq } 6.0\%. Every area mean ought to be inside 90.0-110.0\% of target strength, and all people ought to be inside 75.0-125.0\% of target potency \unskip~\citep{739174:17555213}.

1) Non uniform conveyance of the medication substance all through the powder blend or granulation. 

2) Segregation of the powder blend or granulation during the different assembling forms. 

3) Tablet weight variety. 

The uniform blending of strong medications is basic for guaranteeing content consistency of the last item. This is essential deciding component in the event of medications having tight helpful window and a little change in medicate content (in \ensuremath{\mu }g or mg) adjusting the restorative scope of drugs causing under dose or overdose \unskip~\citep{739174:17555206}. A dry mixing process for low dose drug is possible given that the prepending and blending is planned and process parameters are improved The present article gives an outline on a few detailing methods for low dose drugs with their advantages and disadvantages as far as homogeneity in the completed products\unskip~\citep{739174:17555194} example of low dose drugs accessible in marker.


\begin{table*}[!htbp]
\caption{\boldmath {List of low dose oral drugs} }
\label{tw-45ccd3d74c72}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.1116\linewidth-2\tabcolsep}p{\dimexpr.1928\linewidth-2\tabcolsep}p{\dimexpr.4456\linewidth-2\tabcolsep}p{\dimexpr.25\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}No & Drug & Dose & Category\\
\tblmidrule 
1 &
  Alprazolam &
  250 to 500 \ensuremath{\mu}g three times daily &
  Anxiolytic\\
2 &
  Amiloride hydrochloride &
  Initialy,5 to 10 mg daily: maximum 20 mg daily &
  Diuretics \mbox{}\protect\newline \\
3 &
  Astemizole &
  For adult,10mg(not to be exceeded) once daily up to 7 daily. \mbox{}\protect\newline For children,5 mg(not to be exceeded) once daily up to 7 daily &
  Antihistaminic \mbox{}\protect\newline \\
4 &
  Atropine methonitrate &
  200 to 600 \ensuremath{\mu}g &
  Anticholinergic\\
5 &
  Atropine sulphate &
  250 \ensuremath{\mu}g to 2mg daily in single or divided doses &
  Anticholinergic: Antidote to Chlolinesterase inhibition\\
6 &
  Benzhexol hydrochloride &
  1mg . gradually increased to a usual maintenance dose of 5 to 15 mg daily in 3 to 4 divided doses &
  Antiparkinson\\
7 &
  Betamethasone &
  0.5 to 5 mg daily . in divided doses &
  Adrenocortical steroid\\
8 &
  Bromhexine hydrochloride &
  8 to 16 mg three to four times daily &
  Expectorant\\
9 &
  Bromcriptin \mbox{}\protect\newline emesylate &
  Equivalent of 2.5 mg to 20 mg of bromocriptine daily, in divided doses &
  Dopamine agonist\\
10 &
  Buprenorphine hydrochloride &
  Equivalent of up to 400 \ensuremath{\mu}g of buprenorphine every 6 to 8 hours  &
  Narcotics analgesics\\
11 &
  Busulphan &
  2 to4 mg daily: maintenance dose 0.5 to 2 mg daily &
  Cytotoxic\\
12 &
  Carbimazole &
  Controlling dose ,30 to 40 mg daily, in divided dose: maintenance dose, 5 to 20 mg daily &
  Antithyroid\\
13 &
  Chlorpheninamine maleate &
  4 to 16 mg daily, in divided doses &
  Antihypertensive\\
14 &
  Colchicine &
  Initial dose 1mg: subsequent dose, 500 \ensuremath{\mu}g every two hours &
  Gout suppressant\\
15 &
  Cyproheptadine hydrochloride &
  4 to 20 mg daily, in divided doses &
  Histamine H1-receptorantagonist\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}
\textbf{Tablet content uniformity}

Manufacturing low dose have many problem related to mixing, and the bigger medication particles must be reduced in size before endeavoring to make a homogeneous blend. The impact of molecule size on content consistency has been talked about in the writing \unskip~\citep{739174:17555219}. Be that as it may, it requires a refined comprehension of insights and no exploratory information was given to test the examination given. The target of the present work was to exhibit the impact of medication molecule size on the substance consistency of a low portion tranquilize excipient mix, and to show that basic figuring's could be made to mimic the outcomes. This was done to help approve a computational strategy that would give direction in setting molecule size particulars to maintain a strategic distance from poor substance uniformity \unskip~\citep{739174:17555191}. To guarantee the consistency of measurement units, every unit in a given group should contain the dynamic medication inside a thin range around the mark guarantee. The consistency of measurements units can be assessed either by estimating the substance consistency or the heaviness of the tablets \unskip~\citep{739174:17555205}. The test for weight variety is appropriate for hard cases, uncoated tablets and film-covered tablets containing 25 mg or to a greater degree a medication substance involving 25\% or more, by weight, of the dose unit or, on account of hard cases, the case substance, then again, actually consistency of other medication substances present in lesser extents is shown by meeting the necessities for content consistency. Except if the 25 mg/25\% edge limit is met, the utilization of the mass/weight variety test as an elective test for content consistency isn't viewed as exchangeable in all International Conference on Harmonization (ICH).

\textbf{Tablet disaintagration and friability }

Tablet deterioration was performed utilizing sanitized water at 37C and six tablets tested during the center of each tableting run. The contraption utilized met USP {\textless}701{\textgreater} rules with plates. The time recorded was the ideal opportunity for the last tablet to break down. Tablets from every granulation procedure crumbled in under 1 moment. The composite scope of breaking down occasions from the various procedures is 12{\textendash}55 seconds. Friability was performed by the USP {\textless}1216{\textgreater}. For each test, 26 tablets were friabulated for 100 revolutions \unskip~\citep{739174:17555192}. The tablets were inspected during the center of each tableting run. Tablet friability from all the granulation forms was exceptionally low. The composite range including all procedures was 0{\textendash}0.16\%. No split or broken tablets were watched . Strong measurements structures, for example, tablets cases, despite everything speak to the most boundless innovation to orally oversee dynamic pharmaceutical fixings (API) to the patient. Inside this gathering breaking down tablets comprise by a long shot the main part of pharmaceutical items. By picking appropriate compound and physical properties tablets can be figured to either discharge their API promptly following oral organization (quick discharge tablets) or to change the medication discharge profile with the intend to accomplish improved helpful adequacy, decreased harmfulness, and improved patient consistence and comfort (altered discharge tablets) \unskip~\citep{739174:17555198} . So as to permit quick dissolving tablets to break up in the mouth, they are made of either incredibly penetrable or fragile framed systems or compacted into tablets with low weight power, which makes the tablets friable as well as weak which are hard to deal with, regularly requiring particular strip off rankle pressing. To beat this issue, a few organizations presented progressively vigorous types of quick dissolving tablets \unskip~\citep{739174:17555200,739174:17555208}.

\textbf{Particle size}

Granulation molecule size was estimated for each granulating illness by using sieve analysis. The sieve analysis was completed to decide the geometric mean granule size. Around 5 g of granule test was moved to the highest point of a loaded arrangement of seven pre weighed strainers of diminishing size: 840, 425, 250, 180, 150, 75. furthermore, 45 \ensuremath{\mu }m. The strainers were shaken for 7.5 min with a sufficiency of 6 and heartbeat setting of 6 on a Model L3 Sonic Sifter. Micronized medications may tend to isolate in mixes because of their expanded surface zone and agglomeration. 1,2 To diminish their high surface vitality, microparticles total and structure bigger particles that could cause issues in blending.3,4 Isolation, which is de-blending of a mix, will bring about poor substance and weight consistency just as variety in disintegration, appearance, taste and steadiness of conclusive strong dose structures. Isolation is gear and material ward \unskip~\citep{739174:17555210}. The decision of filler for a low portion mix of micronized medications could be basic to guarantee great dispersability and consistency of a micronized medicate all through the mix with no isolation. Past investigations have demonstrated that Starch 1500{\textsuperscript{\textregistered}}, somewhat pregelatinized maize starch and microcrystalline cellulose (MCC) blends gave magnificent mix consistency, with great compaction and crumbling properties. 5, 6 In this examination, a blend of Starch 1500 and MCC was chosen as the filler. One of the destinations was to assess the impact of medication molecule size on mix isolation of low portion details of micronized hydrochlorothiazide (HCTZ), a somewhat water solvent model medication. The other goal was to ponder the impact of medication molecule size and medication load on disintegration pace of micronized medicate tablets; two focuses, 1\% and 10\% of the micronized tranquilize, were utilized in these investigations \unskip~\citep{739174:17555209}.


\bgroup
\fixFloatSize{images/37b1cced-1b5b-4099-b832-2bee173004df-upicture1.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/37b1cced-1b5b-4099-b832-2bee173004df-upicture1.png}{\includegraphics{images/37b1cced-1b5b-4099-b832-2bee173004df-upicture1.png}}{}
\makeatother 
\caption{\boldmath {Granulation-schematic diagram}}
\label{f-4af4a0a37761}
\end{figure*}
\egroup

\bgroup
\fixFloatSize{images/dfda00fa-25d1-47be-84f9-2948f23650a2-upicture2.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/dfda00fa-25d1-47be-84f9-2948f23650a2-upicture2.png}{\includegraphics{images/dfda00fa-25d1-47be-84f9-2948f23650a2-upicture2.png}}{}
\makeatother 
\caption{\boldmath {Schematic diagram of pneumatic dry granulation}}
\label{f-aaa99b41731b}
\end{figure*}
\egroup

\bgroup
\fixFloatSize{images/d73073d2-9a5b-4f06-a205-a534c636c786-upicture3.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/d73073d2-9a5b-4f06-a205-a534c636c786-upicture3.png}{\includegraphics{images/d73073d2-9a5b-4f06-a205-a534c636c786-upicture3.png}}{}
\makeatother 
\caption{\boldmath {Schematic diagram of foam granulation}}
\label{f-2b39309f2f25}
\end{figure*}
\egroup

\bgroup
\fixFloatSize{images/403b8e82-d1ed-4bea-80bb-1a4570915faa-upicture4.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/403b8e82-d1ed-4bea-80bb-1a4570915faa-upicture4.png}{\includegraphics{images/403b8e82-d1ed-4bea-80bb-1a4570915faa-upicture4.png}}{}
\makeatother 
\caption{\boldmath {Schematic diagram thermo adhesion granulation}}
\label{f-9cba22ccaef7}
\end{figure*}
\egroup
\textbf{Dissolution time}

Throughout the years, the traditional oar and bin disintegration with 1-L vessels has been a huge instrument for portraying the biopharmaceutical nature of item at different stages in the thing life cycle. Our discussion will concentrate on those official contraption contained in the current USP (2, 7). Mechanical assembly referenced in the accompanying areas contain perceived least operational volumes. Meeting with the producers of these device is prescribed to get the most recent exhibition particulars if further decreases in vessel volume are wanted. Mechanical assembly will be examined by their USP device numbers, and extra data will follow every contraption with respect to its noncompendial alterations to accomplish little volume dissolution \unskip~\citep{739174:17555222}. For low groupings of API, official compendial device might be unequipped for keeping up quantitative degrees of studies during the disintegration of oral measurement units containing microgram or nanogram levels. Disintegration of common high-intensity, low-portion mixes may require a decrease in vessel volume joined by a change in device structure because of constraints in recognition and quantitation. In the event that a decrease in volume is considered and the mechanical assembly is changed, the working states of the altered contraption ought to keep up a similar level of exactness and arrangement required for some other compendial disintegration apparatus \unskip~\citep{739174:17555223}. In the current administrative condition, our disintegration strategies must be precise, delicate, and explicit, and the reproducibility of the test technique utilized must be set up, confirmed, and documented. Administrative desires for the little volume disintegration technique should proceed to: \ensuremath{^\circ} Characterize the in vitro discharge from the get-go being developed. \ensuremath{^\circ} Evaluate discharge with different states of tumult, media arrangement, pH, and temperature. \ensuremath{^\circ} Establish ideal test conditions. \ensuremath{^\circ} Demonstrate an arrival of 80\% or an asymptote. The strategy ought to likewise be fit for indicating segregation, dismissing parts, and at last showing consistency of execution from parcel to parcel. As far as disintegration determinations for altered discharge items, desires are tall for in vitro{\textendash}in vivo relationship (IVIVC), and the little volume disintegration device ought to give information expected to help scale-up and post-endorsement changes for adjusted discharge (SUPAC-MR.Moreover, the disintegration test ought to be approvable dependent on important approach and determinations, and when all is said in done, the strategy must be significant, unsurprising, explicit, and discernable \unskip~\citep{739174:17555222}.

\textbf{Granulation method used for low dose drugs}

\textbf{Dry granulation}

Dry granulation can be accomplished by roller compaction or byslugging. The dual distinct sorts are delineated in the schematic chart. There has not been a great deal of progress in the dry granulation procedure and advancement conversely with wet granulation, aside from one significant advancement identified as pneumatic dry granulation technology established by AtacamaLabsOy (Helsinki, Finland) \unskip~\citep{739174:17555207} , In the dry strategies for granulation the essential powder particles are totaled under high weight. There are two fundamental procedures. Either an enormous tablet (known as a 'slug') is created in a substantial tabletting press (a procedure known as 'slugging') or the powder is pressed between two rollers to deliver a sheet of material ('roller compaction'). In the two cases these transitional items are broken utilizing a reasonable processing strategy to create granular material, which is generally sieved to isolate the ideal size part. The unused fine material might be adjusted to evade squander. This dry technique might be utilized for drugs that don't pack well after wet granulation, or those which are touchy to dampness In dry granulation process the powder mix is compressed without the usage of warmth and dissolvable. It is the least appealing of all techniques for granulation. The two basic techniques are to outline a moderate of material by weight and a short time later to process the negligible to obtain a granules. Two techniques are used for dry granulation. The even more comprehensively used methodology is slugging, where the powder is precompressed and the resulting tablet or slug are prepared to yield the granules. The other methodology is to precompress the powder with pressure moves using a machine, for instance, Chilosonator. Steps drew in with dry granulation process are. Figure~\ref{f-4af4a0a37761}

1. Processing of medications and excipients 

2. Blending of processed powders 

3. Pressure into huge, hard tablets to make slug 

4. Screening of slugs 

5. Blending in with oil and breaking down operator 

6. Tablet pressure

\textbf{Pneumatic dry granulation }

Pneumatic dry granulation is an imaginative dry granulation development, uses roller compaction with a prohibitive air request system to convey granules with sensational blend of flowability and compressibility. Right now, are made after powder particles by from the start spreading smooth compaction power through roller compactor to pass on a compacted mass including a blend of fine particles and granules. The fine particles with furthermore more diminutive granules are isolated from the anticipated size granules in a fractioning chamber by entraining in a gas stream (pneumatic framework), while the typical size granules experience the fractioning chamber to be compacted into tablets. The entrained fine particles similarly as meager granules are then moved to a gadget, for instance, brutal breeze and are moreover returned to the roller compactor for brief re-taking care of (reusing or dissemination procedure) or set in a holder for reprocessing later to achieve the granules of needed size.7,8. Pneumatic dry granulation development could adequately used to convey incredible gushing granules for any definitions that produce compacts with an unbending nature of {\texttildeapprox} 0.5 MPa. In like manner, this advancement also enables the use of high medicine piles up to 70-100\%, considering the way that adequate flowability can be cultivated even at lower move compaction powers (lower solid parts) \unskip~\citep{739174:17555208,739174:17555203} contrasted with ordinary roller compaction.9 despite these, this development benefits various favorable circumstances, for instance, faster getting ready speed, ease, no material wastage, low buildup presentation on account of the shut thought of this unit, thus forth.In any case, the effect of reusing the granule quality, propriety with little bit subtleties, friability, etc remains a noteworthy problems concerning this innovation.The schematic chart of this system is addressed as Figure~\ref{f-aaa99b41731b}.

\textbf{Wet granulation }

Wet granulation is for the most part utilized procedure then the granules are delivered by wet massing of the excipients and active pharmaceutical ingredient along with granulation fluid with or without cover. The progression related with traditional wet granulation strategy could be seen in Wet granulation has seen distinctive particular and mechanical headways, for instance, steam granulation, dampness initiated dry granulation or clammy granulation, warm grip granulation, dissolve granulation, freeze granulation, frothed folio or else froth granulation, and invert wet granulation., and switch wet granulation. The importance and imprisonments of the progressing wet granulation systems and developments are sketched out.

\textbf{Foam granulation}

In this type of method, Drugs are dissolved in a form of aqueous binder solution prepared using higher shear granulator and the polymers that are dissolved in other required excipients are also prepared. The formed granules are then compressed to tablets of low dose. \unskip~\citep{739174:17555211} When passed in to high shear granulator, the foamed binders breaks quickly and disperse the content uniformly due to the presence of shaving creams; example: Hypromellose 2910 USP was used in formulation of Propranolol HCL Tablet using foam granulation technique. Content Uniformity testing showed   \%RSD results from 0.31 to 3.8 for granulation Froth granulation or frothed binder granulation technology,, closely resembling spraying accumulation, includes the expansion of fluid/watery cover as froth as opposed to splashing or pouring fluid addition onto the powder particles \unskip~\citep{739174:17555218}. Figure~\ref{f-2b39309f2f25},

\textbf{Thermal adhesion granulation (tag)}

Wei-Ming Pharmaceutical Company (Taipei, Taiwan) has established this technique, and the thermal adhesion granulation, comparable to moist granulation, uses adding of a small quantity of granulation fluid and warmth for agglomeration. This is obviously exhibited in as a schematic graph. Not at all like dampness initiated dry granulation which uses water alone as granulation fluid, this procedure utilizes both water and dissolvable as granulation fluid. Furthermore, heat is utilized to encourage the granulation procedure. Right now, medicate and excipient blend remains warmed to a temperature scope around 30{\textendash}130 \ensuremath{^\circ}C in shut framework under tumble turn to encourage the agglomeration of the powder particles. This method disposes the drying procedure because of the expansion of low measure of granulation fluid, which are generally devoured by the powder particles during accumulation. Granules of the necessary molecule size can be gotten in the wake of cooling0 and sieving \unskip~\citep{739174:17555204}. The impediments of this procedure are prerequisite of significantly high vitality information sources and uncommon gear for heat age and guideline. This method isn't suitable for all binders and it is sensitive to thermolabile drugs \unskip~\citep{739174:17555221}. Figure~\ref{f-9cba22ccaef7}

\textbf{Melt granulation}

This method is widely used for preparing immediate and controlled released formulations such as pellets, granules. This method is accepted for the enhancement of bioavailability and dissolution profile of poorly water soluble drugs by forming solid dispersion. Since a melt able binder is added in a solid state to achieve granulation, it is also known as Thermostatic melt granulation. Melting  range is from 50\ensuremath{^\circ}C to 80\ensuremath{^\circ} C. The binder in the melted state act as granulating liquid which helps in further addition of liquid binder or water and dried granules can be easily obtained by simple cooling. A melt granulation process has been inspected (1, 2) which effectively agglomerates pharmaceutical powders which are used in both immediate and sustained release solid dosage forms. The procedure uses materials that are successful as pulverizing liquids when they are in the liquid state. Cooling of agglomerated powders and the resultant hardening of the liquid materials finishes the granulation procedure. Both liquid agglomeration and cooling cementing stayed cultivated in a high shear Collette Gral blender outfitted with a jacketed bowl. Consequently, the soften granulation process replaces the customary granulation and drying activities which uses water or liquor arrangements. The dissolve granulation process has been examined utilizing prompt and continued discharge the TAVIST{\textsuperscript{\textregistered}} (clemastinefumarate USP) tablet details. TAVIST granulation has been described by power utilization observing, estimation of the granulation molecule size appropriation, mass and tapped thickness judgments, and misfortune on-drying estimations. Scale-up of the dissolve granulation process for supported discharge of TAVIST tablet detailing was made a decision about effective dependent on a correlation of the hardness, friability, weight consistency during pressure, crumbling time, and disintegration rate information got at various assembling scale \unskip~\citep{739174:17555193}.

\textbf{Reverse wet granulation}

In the process of reverse wet granulation, an API is mixed with solution or suspension of hydrophilic polymer to form slurry. By adding a mix of other dry excipients into a drug slurry polymer, the granules can be formed. The granules formed contain a core that comprise of API with poor aqueous solubility with one or more hydrophilic polymers. Granules formed after milling has good characteristic property. Tablets formed from these granules erode uniformly making them to have a good dissolution testing characteristics when compared with conventional techniques. \unskip~\citep{739174:17555217}. The benefits of this method over regular wet granulation incorporate little and round formed granules with enhanced stream possessions, constant wetting and disintegration of the granules. This procedure can be reasonable for ineffective water-solvent medications due to the personal relationship between a medication and the polymer. Ease of use of as of now accessible gear, for example, rapid blender is another value of this procedure. In any case, this strategy delivered granules with a more noteworthy mass mean distance across lower intragranular porosity when contrasted with the traditional wet granulation at binder concentrations \unskip~\citep{739174:17555220}.

\textbf{Freez granulation}

Freeze granulation technology, spray freezing and ensuing freeze drying, includes splashing beads of a fluid slurry or suspension into fluid nitrogen followed by the freeze-drying of the solidified droplets Lyophilization implies drying at low temperature under condition that includes the evacuation of water by sublimation. Medication in a water dissolvable grid which is then stop dried to give profoundly permeable structure \unskip~\cite{739174:17555218}. The tablets arranged by lyophilization crumble quickly in under 5 seconds because of fast infiltration of salivation in pores when put in the oral depression.Lyophilization is helpful for heat delicate medications for example thermo-labile substances. Ahmed et al. arranged lyophilized tablet utilizing solidify drying system \unskip~\citep{739174:17555211}. The lyophilized tablet arranged by scattering drug Ketoprofen in fluid arrangement of exceptionally water solvent bearer comprising of gelatin, glycine and sorbitol in rankle packs and afterward exposed to lyophillization in rankle packs. It was discovered that the expansion in solvency of ketoprofen from lyophilized tablet network was about multiple times more prominent than dissolvability of the plain medication which was because of super saturation created by nebulous type of medication. \unskip~\citep{739174:17555215}

\textbf{Steam granulation}

It is change of wet granulation. Here steam is utilized as folio rather than water. Its few advantages incorporates higher appropriation consistency, higher dissemination rate into powders, increasingly great warm parity  during drying step, steam granules are progressively round, have huge surface region consequently expanded disintegration pace of the medication from granules \unskip~\cite{739174:17555202}, handling time  is shorter in this manner increasingly number of tablets are delivered per cluster, contrasted with the utilization of natural dissolvable water fume is earth well disposed, no wellbeing perils to administrators, no confinement by ICH on follows left in the granules, crisply refined steam is clean and accordingly the complete tally can be monitored, brings down disintegration rate so it can be utilized for the arrangement of taste veiled granules without adjusting accessibility of the medication. The benefits of this procedure include the greater capacity ofvapor to disseminate consistently and diffuse into powder particles, creation of round granules with bigger surface zone, and smaller preparing time sustainable (no contribution of natural diluents) \unskip~\citep{739174:17555199}. A hardware, for example, high-shear blender combined with a steam generator would be sufficient for this strategy. Nonetheless, this strategy needs higher vitality contributions for steam age. In addition, this procedure isn't reasonable for all covers and is touchy to thermolabile medications. The granules delivered by this procedure have higher disintegration rate because of expanded surface region of the granules contrasted with customary wet granulation procedure \unskip~\citep{739174:17555224}.

\textbf{Moisture-activateddry  granulation}

This procedure is a variety of traditional wet granulation method. It utilizes next to no water to enact a fastener and start agglomeration.18 This system includes two stages, 1) wet agglomeration of the powder particles, and 2) dampness ingestion or dissemination. Agglomeration is encouraged by including a limited quantity of water, typically under 5\% (1-4\% ideally), to blend the medication, cover and other excipients \unskip~\citep{739174:17555196}. Agglomeration happens when the pulverizing liquid (water) actuates the folio. When the agglomeration is accomplished, dampness engrossing material, for example, microcrystalline cellulose, silicon dioxide, and so forth is added to encourage the ingestion of abundance dampness. The dampness sponges retain the dampness from the agglomerates, bringing about dampness redistribution inside the powder blend, prompting moderately dry granule blend. During this dampness restructuring process, a portion of the agglomerates stay flawless in size without change, while some bigger agglomerates may break prompting more uniform molecule size circulation. It doesn't require a costly drying venture. The application of Moisture-Activated Dry Granulation to a quick release and controlled- release dosage forms indicated the benefits of wet granulation, for example, expanded molecule size, better stream and compressibility.20,21 Added points of interest of this procedure incorporate wide materialness, time effectiveness and less vitality info, and inclusion of scarcely any procedure factors with appropriateness of nonstop procedure. In any case, this method couldn't be utilized for the readiness of granules that necessitate high medication load for dampness of touchy medications and hygroscopic medications because of security and preparing issues related with these sorts of medications. A high-shear blender combined with a sprayer would be a reasonable hardware for the Moisture-Activated Dry Granulation procedure. A perfect machine ought to be outfitted with effective impellers, sharp edges, and choppers to permit great mass development also appropriate blending of the granulation mass \unskip~\citep{739174:17555196}.
    
\section{Conclusions}
Blending and detailing of low portion drugs are advanced work and includes part of issues related to isolation, content consistency and physical soundness which can be constrained by right choice of material, strategy and machine. New and novel excipients have improved the study of low portion tranquilize detailing. Progression in preparing parameters by improving different forms related parameters has put a stringent control on factors prompting isolation in powder blends. Handling and move steps are limited to build homogeneity in definitions. An outline of late plan strategies for low portion drugs. Low portion tranquilize plans expect micronization to build the quantity of particles of medications which could be mixed with different excipients to build homogeneity in the definition just as last dose structure. The details are planned by different strategies to acquire granules, agglomerates or on the other hand requested blends in order to evade isolation and dealing with issues.

\textbf{Funding Support}

None.

\textbf{Conflict of Interest }

None.
    

\bibliographystyle{pharmascope_apa-custom}

\bibliography{\jobname}
\end{document}
